Cell Line Construction, Screening, and Library Building
Cell Line Construction, Screening, and Library Building
The development of a high-performance cell line is a critical foundation for successful biologics manufacturing. A robust cell line can significantly influence protein expression levels, product quality attributes, process scalability, and overall manufacturing efficiency. Protheragen provides comprehensive cell line construction, screening, and library building services to support biologics development programs, including recombinant proteins, monoclonal antibodies, and other complex biologics. By integrating advanced genetic engineering strategies, efficient screening approaches, and cell line optimization technologies, we help partners establish suitable production cell lines for downstream process development and manufacturing.
Overview of Cell Line Construction, Screening, and Library Building
Cell line construction, screening, and library building represent critical components of biologics development, providing the foundation for establishing efficient and consistent production cell platforms. The process involves genetic modification of host cells, generation of engineered cell populations, screening of high-performing clones, and evaluation of cell characteristics.
A well-designed cell line development workflow helps identify clones with suitable productivity, stability, and product quality profiles, which are essential for successful biologics manufacturing. Cell library building and advanced screening technologies further enable the exploration of diverse cell populations and support the selection of optimized candidates for different therapeutic applications.
These technologies are widely utilized for the development of monoclonal antibodies, recombinant proteins, and other complex biologics, supporting the transition from early research to scalable manufacturing.
Fig.1 Overview on the cell line development process. (Fischer, S., et al., 2017)
Our Services
The successful generation of a production-ready cell line requires coordinated strategies combining molecular engineering, screening technologies, and cell performance evaluation. Protheragen provides flexible cell line development services from early genetic construction to optimized clone selection, supporting different biologic expression requirements.
Cell Line Construction
Comprehensive molecular and functional characterization establishes a detailed understanding of product quality, structure, and biological activity.
Services Include:
Gene Expression Vector Construction
Cell Transfection & Integration
Host Cell Engineering
Cell Screening & Clone Selection
Following cell line construction, efficient screening and clone selection are essential for identifying high-producing and stable cell populations. Protheragen applies screening strategies to evaluate cell growth characteristics, productivity, and product quality attributes.
Services Include:
High-performance Clone Screening
Functional Screening
Clone Selection & Optimization
Cell Library Building
Cell library construction enables the generation and evaluation of diverse cell populations to identify optimized production candidates. Protheragen provides customized library building strategies for biologics discovery and cell engineering applications.
Services Include:
Cell Library Generation
Screening Platform Development
Application-oriented Cell Engineering
Screening & Characterization Technologies
Protheragen integrates advanced analytical and imaging platforms to support efficient clone identification and cell line evaluation.
Technology Platform
Application
qPCR Analysis
Gene integration and expression analysis
Automated Cell Imaging
Single-cell cloning verification and monitoring
Cell Viability Analysis
Growth performance and cell health evaluation
High-throughput Bioanalysis
Protein expression and productivity assessment
Label-free Detection Platform
Real-time molecular interaction and characterization
Applications
Our cell line construction, screening, and library building services support the development of a broad range of antibody-based therapeutics, from conventional monoclonal antibodies to next-generation biologics. By integrating advanced cell engineering, high-throughput screening, and expression optimization strategies, we help accelerate the identification of high-performance producer cell lines for clinical and commercial development.
Monoclonal Antibodies
Development of stable, high‑producing cell lines for therapeutic antibodies with optimized expression, stability, and product quality.
Bispecific & Multispecific Antibodies
Specialized workflows for complex antibody formats, enabling efficient clone selection and improved chain pairing performance.
Fusion Proteins & Engineered Biologics
Cell line solutions for Fc‑fusion proteins, antibody fragments, and other recombinant therapeutic proteins.
Antibody‑Oligonucleotide Conjugates (AOCs)
Customized expression support for antibody components used in next‑generation targeted delivery platforms.
Antibody Libraries & Discovery Platforms
Construction and screening of diverse antibody libraries to facilitate lead identification and optimization.
Complex & Difficult‑to‑Express Molecules
Tailored cell engineering strategies for challenging biologics requiring enhanced expression and manufacturability.
Why Choose Protheragen
Integrated Cell Line Development Platform
Protheragen provides comprehensive solutions covering cell line construction, screening, optimization, and characterization.
Flexible Expression System Support
Our expertise in mammalian expression platforms enables customized strategies for different biologic production requirements.
Efficient Clone Identification Strategies
Advanced screening approaches help identify high-performing clones and reduce development timelines.
Quality-focused Development Approach
Cell line evaluation considers productivity, stability, and product quality attributes to support downstream manufacturing.
Seamless CMC Integration
Cell line development strategies are designed with downstream process development and manufacturing requirements in mind.
Featured Case Studies
Complex antibody molecules often require customized cell line engineering approaches to achieve balanced expression, productivity, and stability. Our platform integrates expression optimization, monoclonal screening, and early process evaluation to accelerate the development of reliable production cell lines.
Rapid Development of a Stable Cell Line for Dual Antibody Production
A dual antibody program was successfully accelerated through optimized transfection strategies, parallel clone screening workflows, and simultaneous evaluation of productivity and stability during early-stage development.
A well-designed production cell line is the foundation of efficient biologics manufacturing. Protheragen combines cell engineering expertise, screening capabilities, and characterization strategies to help partners establish reliable expression systems for next-generation biologics. From initial cell construction to optimized clone selection, our integrated solutions support biologics programs throughout the development lifecycle. Whether you are developing monoclonal antibodies, recombinant proteins, or other biologic therapeutics, Protheragen provides customized cell line construction, screening, and library building services to support your development goals. Contact us discuss your cell line development requirements and explore tailored solutions for your biologics program.
Reference
Fischer, S., et al. "miRNA engineering of CHO cells facilitates production of difficult-to-express proteins and increases success in cell line development" Biotechnol. Bioeng. 2017, 114: 1495-1510.
Fig.1 Overview on the cell line development process. (Fischer, S., et al., 2017)
Monoclonal Antibodies